SCT Associated studies
Open trials
| Short name | TARGET study |
| Study title | Individualized dosing of fludarabine during innate allo SCT: A randomized phase II study |
| Status | Open |
| Participants | NL-LUMC DE-Mainz |
| Study docs | Flow + eligibility Protocol |
| Short name | CMV pp65 specific T-cells |
| Study title | Treatment with CMV pp65‐specific T cells generated by use of a CMV pp65 protein‐spanning peptide pool in patients with CMV reactivation or CMV disease after allogeneic stem cell transplantation (alloSCT) |
| Status | Open (only hospital exemptions allowed) |
| Participants | LUMC |
| Study docs | Flow + eligibility Protocol |
| Short name | HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation |
| Study title | A Dose-Escalation, Open Label Phase I Study to Assess the Safety, Feasibility and Preliminary Efficacy of HA-1H TCR Modified T Cells, MDG1021, in Patients With Relapsed or Persistent Hematologic Malignancies After Allogeneic HSCT With or Without Unmanipulated DLI |
| Reference | NCT04464889 |
| Status | Open |
| Participants | LUMC |
| Short name | TRACE |
| Study title | Treatment of chemo-refractory viral infections after allogeneic stem cell transplantation with multispecific T cells against CMV, EBV and AdV: A phase III, prospective, multicentre clinical trial |
| Reference | Clinical trials register |
| Status | Open |
| Participants | LUMC |